3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Other hematologic neoplasm
1
Lymphoid
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Head and Neck Neoplasms
2
Urologic Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Mesothelioma, Malignant
1
Lymphoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia
1
Breast Neoplasms
1
Interventions
Oxaliplatin
14
sintilimab
10
S 1 (combination)
9
Drug Therapy
7
Capecitabine
5
tislelizumab
4
Surgical Procedures, Operative
4
Paclitaxel
4
HMPL-013
4
apatinib
3
Tegafur
3
Immune Checkpoint Inhibitors
3
Cisplatin
3
Bevacizumab
3
surufatinib
2
potassium oxonate
2
lenvatinib
2
irinotecan sucrosofate
2
gimeracil
2
Observation
2
Injections
2
Hyperthermic Intraperitoneal Chemotherapy
2
Fluorouracil
2
Exercise
2
Endoscopic Mucosal Resection
2
Doxorubicin
2
Albumin-Bound Paclitaxel
2
130-nm albumin-bound paclitaxel
2
zolbetuximab
1
toripalimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Stomach Neoplasms
×
Tissue Banks
×
Clear all
NCT06827639
2025-02-14
FUTURE
Assistance Publique Hopitaux De Marseille
Not yet recruiting
640 enrolled